CDMO turnaround may be delayed
CDMO performance remained soft in Q2; management expects rebound in H2 but any delay in project ramp-ups or regulatory approvals could impact growth.
ALIVUS / bear-case history
Track the concerns that keep returning.
Alivus Life Sciences · risk themes across the available quarters.
Research layer active
Bear-case history
Risks carried through the record.
medium
GPL recovery uncertain
GPL segment declined due to customer inventory rationalization; management expects recovery in H2 but could not quantify, leaving uncertainty.
Capex delays may constrain future growth
Capex spend has been slower than planned; while management says it won't impact near-term growth, delays in capacity expansion could limit medium-term scalability.
Regulatory compliance incident at Gujarat plant
A flash fire led to a penalty from the Gujarat State Pollution Control Board; while management downplays it, repeated issues could affect operations.
Geopolitical instability impacting global business
Management highlighted geopolitical risks as a key concern given the company's international presence, though diversification mitigates impact.
CDMO growth slower than peers due to smaller deal sizes
Analyst questioned why CDMO deal sizes are limited to $4-6M vs peers targeting $50-100M; management defended strategy citing high attrition and tax-driven manufacturing in Ireland.
Pricing erosion in mature molecules
Management acknowledged 4-4.5% annual price erosion across the portfolio, but expects to offset via next-gen processes and new launches.
Sholapur capacity delay and scale-down
Sholapur plant delayed by ~3 months to July 2026, and initial capacity reduced from 600kL to 450-500kL, though management says it won't impact growth.
Geopolitical tariff and supply chain uncertainties
Ongoing geopolitical conflicts and tariff uncertainties could disrupt supply chains and increase logistics and energy costs.
Raw material cost inflation from war
Solvent costs have increased significantly due to the war, though management expects to pass on costs to customers.
Fire incident at H plant impact
A fire at the H plant impacted intermediate production, resulting in a 20 crore loss booked in other expenses, with minor spillover expected in Q1.
Potential delays in CDMO deal closures
Management moderated timing for two CDMO deals to early H2 FY27, indicating possible delays from earlier expectations.